Safe Supply (CSE: SPLY): Venture Capital in Drug Reform
Empowering Transformation for a Safer World
Editorial Feature | Nov 2, 2023
Welcome to Safe Supply (CSE: SPLY), the venture fund trailblazing the safe supply ecosystem that stands proudly at the forefront of the third wave of drug reform—a transformative movement with a steadfast mission to end the war on drugs, save countless lives, and foster a responsible and compassionate approach to psychoactive substances.
With remarkable growth and strategic partnerships, Safe Supply (CSE: SPLY) is the world’s first venture fund investing in the fast-growing safe supply ecosystem.
Saving Lives and Shaping a Brighter Future (CSE: SPLY)
Even though we’ve spent over $1 trillion on fighting the drug war1, the use of cannabis, psychedelics, and cocaine has reached unprecedented levels, with 108,000 opioid-related fatalities recorded in the United States in 2021 alone2.
Safe Supply (CSE: SPLY) steps into this critical moment with a crystal-clear mission: to invest in and incubate companies that are saving lives, shaping a brighter future, and ushering in a responsible conclusion to the war on drugs. This mission is the driving force behind every facet of our work.
Capitalizing on a Billion-Dollar Opportunity (CSE: SPLY)
The demand for change is undeniable, and Safe Supply (CSE: SPLY) is here to lead this monumental shift. In the wake of this reform, the total addressable market stands at a staggering $360 billion3. This is your opportunity to join us and seize a piece of this remarkable market.
Our Unique Approach: Incubating and Investing Across the Value Chain
At Safe Supply (CSE: SPLY), we are not just spectators; we are active participants and innovators in this transformative movement. Our model revolves around incubating and investing across the entire value chain, ensuring that we have a strategic presence where it counts. This approach maximizes our potential to capitalize on emerging opportunities as the market evolves.
Key Highlights: (CSE: SPLY)
- Diversified Portfolio of Assets: Safe Supply (CSE: SPLY)‘s diverse portfolio mitigates risk and enhances stability, ensuring consistent growth potential.
- World-Class Team: Our seasoned team, comprised of industry veterans, steers the company’s strategies and operations.
- High-Velocity Deployment: Safe Supply (CSE: SPLY) prioritizes swift investment deployment to maximize returns, potentially leading to higher yields in shorter durations.
- Early Entry into Emerging Markets: As a pioneer, Safe Supply (CSE: SPLY) capitalizes on opportunities before they become mainstream, offering partners a chance to benefit from emerging markets.
- Strategic Positioning Post Decriminalization: Regulatory changes unlock vast market potentials, and we are poised to capitalize on these changes, tapping into newly accessible revenue streams.
- Efficient Capital Allocation: Capital is judiciously invested in high-potential opportunities, ensuring investments are actively seeking and capitalizing on profitable ventures.
- Diversified Exposure: Safe Supply (CSE: SPLY) spans the value chain of the safe supply sector, providing multiple avenues for growth.
- Commitment to Innovation and Evolution: We are committed to staying at the forefront of this thriving sector, utilizing innovation and adaptation as key drivers for sustained growth and profitability.
Safe Supply (CSE: SPLY) is dedicated to reshaping the future of drug reform, improving lives, and creating a safer and healthier world for all. Our strategic approach, seasoned team, and pioneering spirit position us as the leaders in the third wave of drug reform. Together, we are altering the course of drug policies and forging a safer, more compassionate world.
A Strategic Approach to Partnership (CSE: SPLY)
Safe Supply (CSE: SPLY) strategic approach revolves around forming meaningful partnerships and nurturing companies across the safe supply ecosystem. This approach creates a tightly woven fabric of synergies, generating short-term revenues for Safe Supply (CSE: SPLY) while maximizing the value accretion as partner companies flourish.
The Global Momentum for Reform
The momentum for drug reform is undeniable. It began with Portugal’s groundbreaking decision to decriminalize all drugs in 20014, setting an extraordinary precedent for jurisdictions worldwide, including Oregon, Colorado, and British Columbia. British Columbia, in particular, has embraced this momentum by committing over $1 billion in 20235 to combat the toxic drug supply. This commitment encompasses drug-checking services, overdose prevention initiatives, supervised consumption sites, and prescribed safer supply programs—a comprehensive approach that presents an annual opportunity of $3.2 billion6 for safely supplied cocaine in the region.
We proudly represent the first wave of investors dedicated to this rapidly evolving safe supply ecosystem—a testament to our commitment to ending the fentanyl crisis and exploring the limitless potential of the coca plant. Our visionary team boasts over a decade of experience in drug reform investments, providing us with unparalleled insights into the nuances of this market.
Global Legalization and Rescheduling
Across the globe, the movement towards legalization and rescheduling is gaining unprecedented momentum. For instance, Bern, Switzerland, is preparing to pilot legal cocaine sales7—a bold move that signifies the dynamic shift in drug policies. Similarly, Oregon has pioneered the first legal market for psilocybin services, while Australia has rescheduled psilocybin and MDMA for the treatment of specific mental health conditions8. These groundbreaking changes are unlocking vast opportunities in markets estimated to be worth billions of dollars annually9. Moreover, Colorado is poised to establish the world’s first legal market for plant-based psychedelics, and the FDA is expected to approve MDMA-assisted therapy for PTSD treatment in 202410. Multiple U.S. states, including New York, California, Hawaii, and Connecticut, are actively exploring the creation of legal markets, collectively contributing to a global $12 billion per year industry11.
Foundational Investments that Shape the Future (CSE: SPLY)
Our strategic investments, such as CannaLabs and Safe Supply Licensing Co., serve as the bedrock of the safe supply ecosystem. CannaLabs, licensed by Health Canada, conducts groundbreaking research on psychoactive compounds like MDMA, cocaine, DMT, and ketamine. This research is pivotal in shaping the safe supply landscape and is complemented by analytics and testing services that support safe supply programs in Canada.
Additionally, Safe Supply Licensing Co. is in the late stages of securing a dealer’s license, enabling us to import and test controlled substances, thereby connecting investee companies to a federal license for Schedule 1-3 compounds. These foundational investments solidify our position as pioneers in the evolving landscape of drug reform.
Initiating Change in British Columbia
The Canadian Proince of British Columbia has emerged as a global leader in ending the drug war. This dynamic environment presents an annual opportunity of $3.2 billion for safely supplied cocaine in the region12, and Safe Supply (CSE: SPLY) is at the forefront, ready to capture this opportunity.
Rediscovering the Coca Plant
Once stigmatized because of its association with illicit cocaine production, the coca plant is experiencing a renaissance for its therapeutic potential. Beyond its historical notoriety, the coca leaf offers a plethora of benefits, including increased energy, improved digestion, high nutritional value, support for weight loss, carbohydrate metabolism, and effective pain management. Safe Supply (CSE: SPLY) is working to identify opportunities with the multifaceted coca plant, including a $50 billion market in energy drinks13, a $275 billion market in functional foods14, and a $382 billion market in pharmaceuticals15.
Addressing the Fentanyl Overdose Crisis
The fentanyl overdose crisis has reached alarming proportions. In the last decade, 1.22 million Americans have tragically lost their lives to the opioid epidemic16, with a staggering 74,000 fentanyl-related deaths recorded in 2022 alone17. Safe Supply (CSE: SPLY) confronts this crisis head-on by building companies focused on fentanyl test strips. Once considered “drug paraphernalia” and illegal in the U.S., these strips are now legal in a majority of U.S. states. The global fentanyl test strip market is projected to reach a staggering $12.64 billion per year by 2030, with the U.S. accounting for an impressive $6.77 billion of that by 202718.
Building the Infrastructure for the Future
At Safe Supply (CSE: SPLY), we are driven by a vision that knows no bounds, led by a leadership team whose collective expertise and executive-level prowess have raised and deployed over $3.5 billion in capital, generating an impressive $10 billion in shareholder value across their diverse ventures19. This wealth of experience uniquely positions Safe Supply (CSE: SPLY) to navigate the complex and evolving landscape of drug reform, forging a path that others can follow.
Spearheading Leadership Team
At Safe Supply (CSE: SPLY), we are driven by a vision that knows no bounds, led by a leadership team whose collective expertise and executive-level prowess have raised and deployed over $3.5 billion in capital, generating an impressive $10 billion in shareholder value across their diverse ventures19. This wealth of experience uniquely positions Safe Supply (CSE: SPLY) to navigate the complex and evolving landscape of drug reform, forging a path that others can follow.
Join us in pioneering the future of drug reform, saving lives, and creating a safer, more compassionate world. Safe Supply (CSE: SPLY) represents not only a promising investment but an opportunity to be part of a movement that will redefine the future of drug policies, one that holds both tremendous social value and immense profit potential. Together, we are forging a path towards a safer and brighter future for all.
Get A Free Investor Package
1 https://www.nbcnews.com/meet-the-press/data-download/costs-war-drugs-continue-soar-rcna92032
2https://www.cdc.gov/mmwr/volumes/71/wr/mm7150a2.htm#:~:text=U.S.%20drug%20overdose%20deaths%20increased,estimated%20108%2C000%20deaths%20in%202021.
3 https://safesupply.com
4 https://safesupply.com
5 https://safesupply.com
6 https://safesupply.com
7 https://safesupply.com
8 https://safesupply.com
9 https://safesupply.com
10 https://safesupply.com
11 https://safesupply.com
12 https://safesupply.com
13 https://safesupply.com
14 https://safesupply.com
15 https://safesupply.com
16 https://med.stanford.edu/news/all-news/2022/02/stanford-lancet-report-opioid-crisis.html
17 https://www.manchin.senate.gov/imo/media/doc/china_fentanyl_letter_to_state1.pdf?cb
18 http://www.safesupply.comv
19 http://www.safesupply.com
IMPORTANT NOTICE AND DISCLAIMER
This article is a paid advertisement. Think Ink Marketing and its owners, managers, employees, and assigns (collectively “the Publisher”) is often paid by profiled companies or third parties to organize marketing campaigns, which include the creation and dissemination of these types of communications. In this case, in an effort to enhance public awareness of Safe Supply Streaming Co. Ltd. (“SPLY”) and its securities, SPLY has provided the Publisher with a budget of approximately $10,000.00 USD to cover the costs associated with the creation and distribution of this communication. The Publisher may retain any excess sums after expenses as its compensation. This compensation should be viewed as a major conflict with our ability to be unbiased. Readers should beware that third parties, profiled companies, and/or their affiliates may liquidate shares of the profiled companies at any time, including at or near the time you receive this communication, which has the potential to hurt share prices. Frequently companies profiled in our articles experience a large increase in volume and share price during the course of investor awareness marketing, which often ends as soon as the investor awareness marketing ceases. The investor awareness marketing may be as brief as one day, after which a large decrease in volume and share price may likely occur. This communication is not, and should not be construed to be, an offer to sell or a solicitation of an offer to buy any security. Neither this communication nor the Publisher purport to provide a complete analysis of any company or its financial position. The Publisher is not, and does not purport to be, a broker-dealer or registered investment adviser. This communication is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the company. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the advertised company’s SEC, SEDAR and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk. Past performance does not guarantee future results. This communication is based on information generally available to the public and on interviews with company management, and does not (to the Publisher’s knowledge, as confirmed by SPLY) contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the Publisher cannot guarantee the accuracy or completeness of the information.
SHARE OWNERSHIP.
The Publisher does not own any shares of SPLY and has no information concerning share ownership by others of in SPLY. The Publisher cautions readers to beware that third parties, profiled companies, and/or their affiliates may liquidate shares of the profiled companies at any time, including at or near the time you read the articles on this website and this has the potential to hurt share prices. Frequently companies profiled in such articles experience a large increase in volume and share price during the course of investor awareness marketing, which often ends as soon as the investor awareness marketing ceases.
FORWARD LOOKING STATEMENTS.
This publication contains forward-looking statements, including statements regarding expected continual growth of the featured companies and/or industry. The Publisher notes that statements contained herein that look forward in time, which include everything other than historical information, involve risks and uncertainties that may affect the companies’ actual results of operations. Wherever possible, words such as “predicts”, “projects”, “targets”, “plans”, “expects”, “does not expect”, “budget”, “scheduled”, “estimates”, “forecasts”, “anticipate” or “does not anticipate”, “believe”, “intend” and similar expressions or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative or grammatical variation thereof or other variations thereof, or comparable terminology have been used to identify forward-looking statements. These forward-looking statements include, among other things, statements relating to: (a) revenue generating potential with respect to SPLY’s industry; (b) market opportunity; (c) SPLY’s business plans and strategies; (d) services that SPLY intends to offer; (e) SPLY’s milestone projections and targets; (f) SPLY’s expectations regarding receipt of approval for regulatory applications; (g) SPLY’s intentions to expand into other jurisdictions including the timeline expectations relating to those expansion plans; and (h) SPLY’s expectations regarding its ability to deliver shareholder value. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, as of the date of this document including, without limitation, assumptions about: (a) the ability to raise any necessary additional capital on reasonable terms to execute SPLY’s business plan; (b) that general business and economic conditions will not change in a material adverse manner; (c) SPLY’s ability to procure equipment and operating supplies in sufficient quantities and on a timely basis; (d) SPLY’s ability to enter into contractual arrangements; (e) the accuracy of budgeted costs and expenditures; (f) SPLY’s ability to attract and retain skilled personnel; (g) political and regulatory stability; (h) the receipt of governmental, regulatory and third-party approvals, licenses and permits on favorable terms; (i) changes in applicable legislation; (j) stability in financial and capital markets; and (k) expectations regarding the level of disruption as a result of COVID-19. Such forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of SPLY to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: (a) SPLY operations could be adversely affected by possible future government legislation, policies and controls or by changes in applicable laws and regulations; (b) public health crises such as the COVID-19 pandemic may adversely impact SPLY’s business; (c) the volatility of global capital markets; (d) political instability and changes to the regulations governing SPLY’s business operations (e) SPLY may be unable to implement its growth strategy; and (f) increased competition. Except as required by law, the Website Host undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise.
INDEMNIFICATION/RELEASE OF LIABILITY.
By reading this communication, you acknowledge that you have read and understand this disclaimer, and further that to the greatest extent permitted under law, you release the Publisher, its affiliates, assigns and successors from any and all liability, damages, and injury from this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.
INTELLECTUAL PROPERTY.
Think Ink Marketing is the Publisher’s trademark. All other trademarks used in this communication are the property of their respective trademark holders. The Publisher is not affiliated, connected, or associated with, and is not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made by the Publisher to any rights in any third-party trademarks.
IMPORTANT NOTICE AND DISCLAIMER
This website is owned and hosted by Market Tactic Media Ltd. Articles appearing on this website should be considered paid advertisements. Market Tactic Media Ltd. and its owners, managers, employees, and assigns (collectively “the Website Host”) is often paid by marketing companies to host websites on which articles profiling public companies are published. The Website Host has not been compensated by any of the profiled companies. The Website Host’s compensation for articles appearing on this website is as follows:
The Website Host has been paid approximately $500 per week while the advertisement campaign is active by Think Ink Marketing as compensation to host the article profiling Safe Supply Streaming Co. Ltd. (“SPLY”).
SHARE OWNERSHIP
The Website Host does not own any shares of any profiled compannies and has no information concerning share ownership by others of any profiled companies. The Website Host cautions readers to beware that third parties, profiled companies, and/or their affiliates may liquidate shares of the profiled companies at any time, including at or near the time you read the articles on this website and this has the potential to hurt share prices. Frequently companies profiled in such articles experience a large increase in volume and share price during the course of investor awareness marketing, which often ends as soon as the investor awareness marketing ceases.
NO SECURITIES OFFERED
The articles on this website are not, and should not be construed to be, offers to sell or solicitations of an offer to buy any security. Neither the articles on this website nor the Website Host purport to provide a complete analysis of SPLY or its financial position. The Website Host is not, and does not purport to be, a broker-dealer or registered investment adviser. The articles on this website are not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about SPLY Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in SPLY’s SEC, SEDAR and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk.
INDEMNIFICATION/RELEASE OF LIABILITY
By reading articles on this website, you acknowledge that you have read and understood this disclaimer, and further that to the greatest extent permitted under law, you release the Website Host, its affiliates, assigns and successors from any and all liability, damages, and injury from articles appearing on this website. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.
LINKS TO THIRD PARTY WEBSITES
This website enables users to link to external websites not under the control of The Website Host. The Website Host has no control over the nature, content, and availability of those sites. The inclusion of any links is not intended as, and should not be construed as, a recommendation or endorsement of the content or views expressed on such external websites. The Website Host expressly disclaims any representation concerning the quality, safety, suitability, or reliability of any external websites and the content and materials contained in them. It is important for users to take necessary precautions, especially to ensure appropriate safety.
INTELLECTUAL PROPERTY
The Market Tactic is the Website Host’s trademark. All other trademarks used in this communication are the property of their respective trademark holders. The Website Host is not affiliated, connected, or associated with, and is not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made by the Website Host to any rights in any third-party trademarks.
FORWARD LOOKING INFORMATION
This document contains forward-looking information and forward-looking statements, within the meaning of applicable Canadian securities legislation, (collectively, “forward-looking statements”), which reflect expectations regarding SPLY’s future growth, future business plans and opportunities, expected activities, and other statements about future events, results or performance. Wherever possible, words such as “predicts”, “projects”, “targets”, “plans”, “expects”, “does not expect”, “budget”, “scheduled”, “estimates”, “forecasts”, “anticipate” or “does not anticipate”, “believe”, “intend” and similar expressions or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative or grammatical variation thereof or other variations thereof, or comparable terminology have been used to identify forward-looking statements. These forward-looking statements include, among other things, statements relating to: (a) revenue generating potential with respect to SPLY’s industry; (b) market opportunity; (c) SPLY’s business plans and strategies; (d) services that SPLY intends to offer; (e) SPLY’s milestone projections and targets; (f) SPLY’s expectations regarding receipt of approval for regulatory applications; (g) SPLY’s intentions to expand into other jurisdictions including the timeline expectations relating to those expansion plans; and (h) SPLY’s expectations regarding its ability to deliver shareholder value. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, as of the date of this document including, without limitation, assumptions about: (a) the ability to raise any necessary additional capital on reasonable terms to execute SPLY’s business plan; (b) that general business and economic conditions will not change in a material adverse manner; (c) SPLY’s ability to procure equipment and operating supplies in sufficient quantities and on a timely basis; (d) SPLY’s ability to enter into contractual arrangements; (e) the accuracy of budgeted costs and expenditures; (f) SPLY’s ability to attract and retain skilled personnel; (g) political and regulatory stability; (h) the receipt of governmental, regulatory and third-party approvals, licenses and permits on favorable terms; (i) changes in applicable legislation; (j) stability in financial and capital markets; and (k) expectations regarding the level of disruption as a result of COVID-19. Such forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of SPLY to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: (a) SPLY’s operations could be adversely affected by possible future government legislation, policies and controls or by changes in applicable laws and regulations; (b) public health crises such as the COVID-19 pandemic may adversely impact SPLY’s business; (c) the volatility of global capital markets; (d) political instability and changes to the regulations governing SPLY’s business operations (e) SPLY may be unable to implement its growth strategy; and (f) increased competition. Except as required by law, the Website Host undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise.
HISTORICAL INFORMATION
Any graphs, tables or other information demonstrating the historical performance or current or historical attributes of SPLY or any other entity contained in this document are intended only to illustrate historical performance or current or historical attributes of SPLY or such entities and are not necessarily indicative of future performance of SPLY or such entities.